Ary tumor. (A and B) Quantification of macrophages and MMP-9 in

Ary tumor. (A and B) Quantification of macrophages and MMP-9 in lung tissue from mice without tumor by immunohistochemistry staining. Both were directly reduced by IFN-a, and the reversal of both was observed after IFN-a withdrawal; reductions were still much less than the control group. (Right) Representative lung tissue from three groups. In upper panels macrophages are indicated by arrows; lower panels show MMP-9 expression; bars, SEM; **P,0.01, ***P,0.001. Black bars, 50 mm. doi:10.1371/journal.pone.0058913.gIFN-a 6 Transforms the Lung MicroenvironmentFigure 4. IFN-a reduced MMP-9 positive macrophages. The F4/80 (the marker of macrophages, red) and MMP-9 (green) signals were due to TR- and FITC-labeled antibodies, respectively, using single-layer projections in a confocal microscope. Nuclei were labeled by DAPI (blue); 620 objective magnification.The immunofluorescence assays showed macrophages may be one of the major sources of MMP-9 in lung tissues, and IFN-a reduced MMP-9 positive macrophages. doi:10.1371/journal.pone.0058913.gIL-12 in IFN-a and NS group, expressed in 22DCT, respectively), which supported the possibility that IFN-a treatment induces a shift from M2 to M1 polarization in the lung tissues.DiscussionIn the present study, we found that the growth of HCC metastatic foci in the lung was suppressed because of a direct modulation of the lung microenvironment by IFN-a treatment, probably through inhibition of both MMP-9 Licochalcone-A custom synthesis expression and macrophage infiltration in the lung tissues. The cascade of metastasis includes early steps, such as cells from a primary tumor entering into the circulation, survival of the cells in the circulation, and arrest in a new organ, followed by later steps, such as extravasation into the target tissue, initiation and maintenance of growth, and angiogenesis of the metastatic tumor. In vivo videomicroscopy and cell-fate analysis have shown that the early steps in metastasis are efficient, while the later steps are inefficient because the ability to grow is dictated by molecular interactions of the cells with the environment in the secondary organ [25]. This pattern is consistent with our order Lecirelin findings that the incidence of lung metastasis and the number of CTCs in IFN-a?treated and untreated groups were similar, whereas the growth of lung metastasis was inhibited by IFN-a treatment. However, we found that several prominent angiogenic factors such as VEGF-A, PDGF-A, and IL-6 in the metastatic tumor cells were not inhibited, while all these factors were significantly inhibited by IFN-a in the primary tumor site[14]. This suggested that IFN-a selected for a subpopulation of tumor cells that were distinct from the predominant population of primary tumor cells and may have been resistant to IFN-a at the secondary metastatic organs. 1527786 Therefore, it seems unlikely that inhibition of growth of lung metastasis was mediated by the anti-angiogenic property of IFN-a. The most interesting finding is that IFN-a treatment could directly modulate the lung microenvironment to inhibit the growth of lung metastasis; the macrophages and MMP-9 expression in the lungs could be the target of IFN-a treatment. There are two types of macrophages, presenting either a tumoricidal effect (M1) or a pro-tumor effect (M2) [34]. In our present study, based on thecytokine expression pattern in lung tissue, we found IFN-a treatment was associated with a shift of macrophage phenotype from M2 to M1 within the tumor environment. This suggests.Ary tumor. (A and B) Quantification of macrophages and MMP-9 in lung tissue from mice without tumor by immunohistochemistry staining. Both were directly reduced by IFN-a, and the reversal of both was observed after IFN-a withdrawal; reductions were still much less than the control group. (Right) Representative lung tissue from three groups. In upper panels macrophages are indicated by arrows; lower panels show MMP-9 expression; bars, SEM; **P,0.01, ***P,0.001. Black bars, 50 mm. doi:10.1371/journal.pone.0058913.gIFN-a 6 Transforms the Lung MicroenvironmentFigure 4. IFN-a reduced MMP-9 positive macrophages. The F4/80 (the marker of macrophages, red) and MMP-9 (green) signals were due to TR- and FITC-labeled antibodies, respectively, using single-layer projections in a confocal microscope. Nuclei were labeled by DAPI (blue); 620 objective magnification.The immunofluorescence assays showed macrophages may be one of the major sources of MMP-9 in lung tissues, and IFN-a reduced MMP-9 positive macrophages. doi:10.1371/journal.pone.0058913.gIL-12 in IFN-a and NS group, expressed in 22DCT, respectively), which supported the possibility that IFN-a treatment induces a shift from M2 to M1 polarization in the lung tissues.DiscussionIn the present study, we found that the growth of HCC metastatic foci in the lung was suppressed because of a direct modulation of the lung microenvironment by IFN-a treatment, probably through inhibition of both MMP-9 expression and macrophage infiltration in the lung tissues. The cascade of metastasis includes early steps, such as cells from a primary tumor entering into the circulation, survival of the cells in the circulation, and arrest in a new organ, followed by later steps, such as extravasation into the target tissue, initiation and maintenance of growth, and angiogenesis of the metastatic tumor. In vivo videomicroscopy and cell-fate analysis have shown that the early steps in metastasis are efficient, while the later steps are inefficient because the ability to grow is dictated by molecular interactions of the cells with the environment in the secondary organ [25]. This pattern is consistent with our findings that the incidence of lung metastasis and the number of CTCs in IFN-a?treated and untreated groups were similar, whereas the growth of lung metastasis was inhibited by IFN-a treatment. However, we found that several prominent angiogenic factors such as VEGF-A, PDGF-A, and IL-6 in the metastatic tumor cells were not inhibited, while all these factors were significantly inhibited by IFN-a in the primary tumor site[14]. This suggested that IFN-a selected for a subpopulation of tumor cells that were distinct from the predominant population of primary tumor cells and may have been resistant to IFN-a at the secondary metastatic organs. 1527786 Therefore, it seems unlikely that inhibition of growth of lung metastasis was mediated by the anti-angiogenic property of IFN-a. The most interesting finding is that IFN-a treatment could directly modulate the lung microenvironment to inhibit the growth of lung metastasis; the macrophages and MMP-9 expression in the lungs could be the target of IFN-a treatment. There are two types of macrophages, presenting either a tumoricidal effect (M1) or a pro-tumor effect (M2) [34]. In our present study, based on thecytokine expression pattern in lung tissue, we found IFN-a treatment was associated with a shift of macrophage phenotype from M2 to M1 within the tumor environment. This suggests.